FDA lets Zyn market pouches as safer than cigarettes

In a significant move that could reshape the nicotine product landscape, the US Food and Drug Administration (FDA) has given the green light to Swedish Match, the maker of ZYN nicotine pouches, to market its products as a safer alternative to traditional cigarettes. The decision allows the company to make explicit claims about the relative safety of its products, which could have a major impact on consumer behavior and the broader tobacco industry. ZYN pouches, which have become increasingly popular in recent years, contain nicotine without tobacco, and the FDA's ruling could pave the way for similar products to enter the market. The move is part of a broader effort to reduce the harm caused by tobacco products and provide smokers with safer alternatives.

Click in for more news from The Hill {beacon} Healthcare Health Care   The Big Story FDA lets Zyn market pouches as safer than cigarettes The maker of ZYN nicotine pouches can tell consumers its products are safer to use than cigarettes, the FDA said. © Photo credit The ‌FDA allowed the company to market 10...